Acute Porphyria Drugs

Monograph

A06AB08 - Sodium Picosulfate
Not porphyrinogenic
NP

Rationale
Probably insignificant systemic exposure.
Chemical description
Contact laxative giving rise in the colon to free phenols that inhibit water resorbtion, administered perorally in a dose o5 5-10 mg/d. No data on systemic absorbtion. Used in Swedish porphyria wards.
IPNet drug reports
Uneventful use reported in 5 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes A06A / A06AB or go back.
References
Tradenames

Dulcolax Picosulphate · Fructines · Laxoberon Contumax · Dulcolaxo Picosulfato · Evacuol · Lubrilax Dulcolax · Stadalax Dulcopic Dulcolax Picosulfat · Laxasan · Laxoberon · Picosulfat Crescent Pharma Liquid Laxative · Dulcolax Pico · Dulcolax Pico Adult · Dulcolax Pico Twelve Plus · OTC Concepts Liquid Laxative · Sodium picosulfate Actilax · Laxoberal · Orilaxal Laxoberal Pikopil Laxoberon Laxoberal Laxoberon · Picorion Guttalax · Regulax Picosulphate Guttalax · Regulax Picosulphate Guttalax · Laxygal · Pico-Salax · Regulax Pikosulfaat
In cooperation with IpNet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙